Browsing Tag
Drug discovery
46 posts
Absci, PrecisionLife collaborate to develop novel biotherapeutics for chronic diseases
Absci (Nasdaq: ABSI), a generative AI drug creation company, and PrecisionLife, a leader in computational biology, today announced…
December 20, 2023
Perpetual Medicines secures $8m for peptide drug discovery platform
Perpetual Medicines, a frontrunner in computational peptide therapeutics, recently announced an impressive $8 million seed financing round, spearheaded…
December 1, 2023
CAS, Molecule.one to collaborate on advanced synthesis design technologies
In a significant development in the realm of drug discovery, CAS, a subsidiary of the American Chemical Society,…
August 12, 2023
Hewlett Packard Enterprise to build TSUBAME4.0 supercomputer for Tokyo Tech
Hewlett Packard Enterprise (HPE) has been chosen to construct the TSUBAME4.0 by the Tokyo Institute of Technology (Tokyo…
May 20, 2023
BioNTech to buy UK-based tech firm InstaDeep for AI-powered drug discovery
German biotechnology company BioNTech has agreed to acquire 100% of the remaining InstaDeep shares for an upfront consideration…
January 11, 2023
Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline
Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million,…
February 16, 2022
Roivant Sciences enters into $7.3bn merger with Montes Archimedes Acquisition
Roivant Sciences has agreed to merge with Montes Archimedes Acquisition (MAAC), a Nasdaq-listed special purpose acquisition company, in…
May 4, 2021
Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership
AI drug discovery software company Model Medicines has signed a multi-target collaboration agreement with California-based Sanford Burnham Prebys…
March 23, 2021
Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities
Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450…
February 26, 2021
Pfizer partners with PostEra to speed up drug discovery using machine learning technology
In an exciting new development, Pfizer has teamed up with PostEra, a leading biotech company specializing in machine…
December 7, 2020